Mirum Pharmaceuticals (MIRM) EBT Margin (2021 - 2026)
Mirum Pharmaceuticals' quarterly EBT Margin came in at 493.91% in Q1 2026, down 48168.0% year-on-year from N/an in Q1 2025, and down 14721.61% quarter-over-quarter from 3.33% in Q4 2025.
Mirum Pharmaceuticals has reported EBT Margin for 6 years, with the latest figure at 493.91% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin fell 48168.0% year-over-year to 493.91%; the trailing twelve-month figure through Mar 2026 stood at 140.0% (down 11999.0% YoY), and the FY2025 full-year result was 4.11%, up 2169.0% from the prior year.
- EBT Margin for Q1 2026 stood at 493.91%, down from 3.33% in the prior quarter.
- The five-year high for EBT Margin was 1.99% in Q3 2025, with the low at 493.91% in Q1 2026.
- Average EBT Margin over 5 years is 106.16%, with a median of 48.9% recorded in 2023.
- Peak annual rise in EBT Margin reached 75192 bps in 2022, while the deepest fall reached 196427 bps in 2022.
- Tracing MIRM's EBT Margin over 5 years: stood at 130.05% in 2022, then jumped by 61 bps to 50.94% in 2023, then surged by 52 bps to 24.51% in 2024, then jumped by 86 bps to 3.33% in 2025, then tumbled by 14722 bps to 493.91% in 2026.
- The last three EBT Margin figures came in at 493.91% (Q1 2026), 3.33% (Q4 2025), and 1.99% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -6.40% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 41.95% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 23.05% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 18.99% |
| 10 | Mirum Pharmaceuticals | 5.97 Bn | 5.59 Bn | 131.08 Mn | -493.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -493.91% |
| Dec 31, 2025 | -3.33% |
| Sep 30, 2025 | 1.99% |
| Jun 30, 2025 | -4.27% |
| Mar 31, 2025 | -12.23% |
| Dec 31, 2024 | -24.51% |
| Sep 30, 2024 | -15.37% |
| Jun 30, 2024 | -30.82% |
| Mar 31, 2024 | -35.62% |
| Dec 31, 2023 | -50.94% |
| Sep 30, 2023 | -48.90% |
| Jun 30, 2023 | -196.61% |
| Mar 31, 2023 | -94.72% |
| Dec 31, 2022 | -130.05% |
| Sep 30, 2022 | -190.06% |
| Jun 30, 2022 | -191.56% |
| Mar 31, 2022 | -283.86% |
| Dec 31, 2021 | 1,834.23% |
| Sep 30, 2021 | -941.98% |
| Jun 30, 2021 | -398.94% |